Buprenorphine-naloxone may decrease dependence in patients addicted to prescription opioids, but only after extended and/or ongoing treatment. Medscape Medical News (Source: Medscape Today Headlines)

I recently blogged about Buprenorphine, a medication that can help get heroin and other opiate addicts through detox and heroin withdrawal. Today, I’m writing about another medication, Suboxone. Suboxone contains Buprenorphine, but it also contains another ingredient that helps with the process of overcoming addiction. And research shows that it can help with relapse prevention […]

Buprenorphine is an effective treatment for opiate dependence. Prisoners with histories of opiate dependence who are inducted on buprenorphine prior to release are at decreased risk of post-release relapse and overdose, yet many clinicians are unaware of the risks related to buprenorphine induction for non-opiate tolerant patients, especially those on other psychotropic medications. The authors […]

WARREN, N.J., Nov. 30, 2011 (GLOBE NEWSWIRE) — MonoSol Rx, LLC (“MonoSol Rx”), the developer of PharmFilm(r) drug delivery technology and a drug delivery company specializing in film pharmaceutical products, announced that the U.S. Food and Drug Administration (FDA) has listed MonoSol Rx’s U.S. Patent No. 8,017,150 in the Orange Book for the Suboxone(r) (buprenorphine […]